Abaxis (ABAX) Completes Purchase of QCR & Trio Diagnostics
Tweet Send to a Friend
Abaxis (NASDAQ: ABAX) announced the completion of a stock purchase agreement to acquire 100% of QCR & Trio Diagnostics Limited ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE